COVID-19 had a mild clinical course in patients with Agammaglobulinemia lacking B lymphocytes, whereas it developed aggressively in Common Variable Immune Deficiency. Our data offer mechanisms for possible therapeutic targets.

A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia

Cinetto, Francesco
Investigation
;
Agostini, Carlo
Writing – Original Draft Preparation
;
2020

Abstract

COVID-19 had a mild clinical course in patients with Agammaglobulinemia lacking B lymphocytes, whereas it developed aggressively in Common Variable Immune Deficiency. Our data offer mechanisms for possible therapeutic targets.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3337694
Citazioni
  • ???jsp.display-item.citation.pmc??? 164
  • Scopus 262
  • ???jsp.display-item.citation.isi??? 242
social impact